New device aims to filter toxic iron from blood in liver failure patients
NCT ID NCT06340269
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new medical device called MEX-CD1 in 11 adults with acute-on-chronic liver failure (ACLF), a serious condition where the liver suddenly stops working. The device works like a dialysis machine to filter excess iron from the blood. The main goals were to see if the device is safe and if it removes iron as expected. Each participant received three treatments over one week.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE-ON-CHRONIC LIVER FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Pontchaillou
Rennes, 35000, France
-
Hôpital Croix Rousse, Service d'hépatologie et gastroentérologie
Lyon, Auvergne-Rhône-Alpes, 69317, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental injection aims to combat Life-Threatening liver failure
- Blood transfusion strategy could be refined for liver patients
- Could stem cells offer a lifeline for sudden liver failure?
- Gene link to ICU blood sugar problems found
- Gut feeling could save lives: new score may improve ICU death predictions
- New device aims to filter toxins in liver crisis